Mesenchymal stromal cell biotherapy for Parkinson's disease premotor symptoms [0.03%]
间充质基质细胞生物疗法在帕金森病前驱期症状中的应用
Jinmei Sun,Wei Zhang,Zheng Zachory Wei et al.
Jinmei Sun et al.
Parkinson's disease (PD) is a neurodegenerative disorder with motor deficits due to nigrostriatal dopamine depletion and with the non-motor/premotor symptoms (NMS) such as anxiety, cognitive dysfunction, depression, hyposmia, and sleep diso...
Expression of TXLNA in brain gliomas and its clinical significance: a bioinformatics analysis [0.03%]
TXLNA在脑胶质瘤中的表达及其临床意义的生物信息学分析
Bowen Hu,Desheng Chen,Yang Li et al.
Bowen Hu et al.
Background: To analyze the expression of TXLNA in brain gliomas and its clinical significance. Methods: Gene Expression Profiling Inter...
MR-guided laser interstitial thermal therapy for drug-resistant lesional epilepsy: a single-center experience [0.03%]
基于病变的药物难治性局灶性癫痫磁共振引导激光间质热疗的单中心经验
Hongchuan Niu,Kai Li,Xiaoning Liang et al.
Hongchuan Niu et al.
Background: To describe and report the efficacy and safety of MR-guided laser interstitial thermal therapy (MRgLITT) in the treatment of drug-resistant epilepsy. ...
Resection of high-grade glioma involving language areas assisted by multimodal techniques under general anesthesia: a retrospective study [0.03%]
全身麻醉下多模式技术引导的语言脑区高级别胶质瘤切除术：回顾性研究
Meng Cui,Yukun Liu,Chunhui Zhou et al.
Meng Cui et al.
Background: Multimodal techniques-assisted resection of glioma under general anesthesia (GA) has been shown to achieve similar clinical outcomes as awake craniotomy (AC) in some studies. In this study, we aim to validate ...
A deep-learning system to help make the surgical planning of coil embolization for unruptured intracranial aneurysms [0.03%]
一种深度学习系统 辅助制定未破裂颅内动脉瘤线圈栓塞手术计划
Xin Nie,Yi Yang,Qingyuan Liu et al.
Xin Nie et al.
Background: Coil embolization is a common method for treating unruptured intracranial aneurysms (UIAs). To effectively perform coil embolization for UIAs, clinicians must undergo extensive training with the assistance of ...
Surgical site infections after elective craniotomy for brain tumor: a study on potential risk factors and related treatments [0.03%]
脑肿瘤择期开颅术后手术部位感染及相关风险因素和治疗研究
Yifan Lv,Xiang Mao,Yuxuan Deng et al.
Yifan Lv et al.
Background: Surgical site infection (SSI) is a common complication following craniotomy that increases morbidity, mortality, and medical expenses. The objectives of this study were to determine the relevant risk factors a...
Pipeline versus Tubridge in the treatment of unruptured posterior circulation aneurysms [0.03%]
Pipeline和Tubridge在未破裂后循环动脉瘤治疗中的应用探讨
Hengwei Jin,Jian Lv,Xiangyu Meng et al.
Hengwei Jin et al.
Background: To compare the safety and efficacy of pipeline embolization device (PED) and Tubridge flow diverter (TFD) for unruptured posterior circulation aneurysms. ...
Predictors and dynamic online nomogram for postoperative delayed hyponatremia after endoscopic transsphenoidal surgery for pituitary adenomas: a single-center, retrospective, observational cohort study with external validation [0.03%]
术后垂体腺瘤内镜经鼻手术后低钠血症的预测因素及动态在线列线图：单中心回顾性队列研究（含外部验证）
Xiangming Cai,An Zhang,Peng Zhao et al.
Xiangming Cai et al.
Background: Postoperative delayed hyponatremia (PDH) is a major cause of readmission after endoscopic transsphenoidal surgery (eTSS) for pituitary adenomas (PAs). However, the risk factors associated with PDH have not bee...
Endoscopy-assisted purely total outer wall excision for pediatric Sylvian arachnoid cysts [0.03%]
内镜辅助下儿童大脑外侧裂蛛网膜囊肿皮层下完全切除术
Mingxing Wu,Fei Di,Mingle Ma et al.
Mingxing Wu et al.
Background: To present a novel endoscopy-assisted surgical strategy of Sylvian arachnoid cysts (ACs). Case presentation: Endoscopy-assi...
PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trial [0.03%]
PTPRZ1-MET融合基因(ZM-FU_GENE)试验：一项多中心、随机、开放性II/III期临床试验方案
Zhaoshi Bao,Shouwei Li,Liang Wang et al.
Zhaoshi Bao et al.
Background: PTPRZ1-MET fusion was reported to associate with glioma progression from low-grade to high-grade glioma, which was a target by a MET inhibitor vebreltinib. However, little is known about the further efficacy o...